These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24292720)

  • 21. IFITM1 increases osteogenesis through Runx2 in human alveolar-derived bone marrow stromal cells.
    Kim BS; Kim HJ; Kim JS; You YO; Zadeh H; Shin HI; Lee SJ; Park YJ; Takata T; Pi SH; Lee J; You HK
    Bone; 2012 Sep; 51(3):506-14. PubMed ID: 22634173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoblastic cells: differentiation and trans-differentiation.
    Kassem M; Abdallah BM; Saeed H
    Arch Biochem Biophys; 2008 May; 473(2):183-7. PubMed ID: 18406334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue.
    Deschaseaux F; Gaillard J; Langonné A; Chauveau C; Naji A; Bouacida A; Rosset P; Heymann D; De Pinieux G; Rouas-Freiss N; Sensébé L
    FASEB J; 2013 Aug; 27(8):2977-87. PubMed ID: 23592762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of zinc transporter on differentiation of bone marrow mesenchymal stem cells to osteoblasts.
    Liu Y; Yan F; Yang WL; Lu XF; Wang WB
    Biol Trace Elem Res; 2013 Aug; 154(2):234-43. PubMed ID: 23775599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoids and bone: local effects and systemic implications.
    Henneicke H; Gasparini SJ; Brennan-Speranza TC; Zhou H; Seibel MJ
    Trends Endocrinol Metab; 2014 Apr; 25(4):197-211. PubMed ID: 24418120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda.
    Baron R; Gertner JM; Lang R; Vignery A
    Pediatr Res; 1983 Mar; 17(3):204-7. PubMed ID: 6835724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteocytes: central conductors of bone biology in normal and pathological conditions.
    Neve A; Corrado A; Cantatore FP
    Acta Physiol (Oxf); 2012 Mar; 204(3):317-30. PubMed ID: 22099166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell Death in Chondrocytes, Osteoblasts, and Osteocytes.
    Komori T
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27929439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteogenesis imperfecta tarda. The morphology of rib biopsies.
    Albright JP; Albright JA; Crelin ES
    Clin Orthop Relat Res; 1975 May; (108):204-13. PubMed ID: 1139829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Osteoimmunology: how inflammation influences bone metabolism].
    Lange U; Teichmann J; Schett G; Neumann E; Müller-Ladner U
    Dtsch Med Wochenschr; 2013 Sep; 138(37):1845-9. PubMed ID: 24006167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low bone mass and changes in the osteocyte network in mice lacking autophagy in the osteoblast lineage.
    Piemontese M; Onal M; Xiong J; Han L; Thostenson JD; Almeida M; O'Brien CA
    Sci Rep; 2016 Apr; 6():24262. PubMed ID: 27064143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis.
    Borton AJ; Frederick JP; Datto MB; Wang XF; Weinstein RS
    J Bone Miner Res; 2001 Oct; 16(10):1754-64. PubMed ID: 11585338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.
    Lee NJ; Doyle KL; Sainsbury A; Enriquez RF; Hort YJ; Riepler SJ; Baldock PA; Herzog H
    J Bone Miner Res; 2010 Aug; 25(8):1736-47. PubMed ID: 20200977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development, physiology, and cell activity of bone].
    de Baat P; Heijboer MP; de Baat C
    Ned Tijdschr Tandheelkd; 2005 Jul; 112(7):258-63. PubMed ID: 16047964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bone and Stem Cells. Regulatory mechanism of mesenchymal stem cell differentiation to osteoblasts].
    Endo I; Mastumoto T
    Clin Calcium; 2014 Apr; 24(4):555-64. PubMed ID: 24681502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of osteoblasts and osteocytes from mesenchymal stem cells.
    Heino TJ; Hentunen TA
    Curr Stem Cell Res Ther; 2008 May; 3(2):131-45. PubMed ID: 18473879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies as tools for studying the osteoblast lineage.
    Aubin JE; Turksen K
    Microsc Res Tech; 1996 Feb; 33(2):128-40. PubMed ID: 8845513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TLE3, transducing-like enhancer of split 3, suppresses osteoblast differentiation of bone marrow stromal cells.
    Kokabu S; Nguyen T; Ohte S; Sato T; Katagiri T; Yoda T; Rosen V
    Biochem Biophys Res Commun; 2013 Aug; 438(1):205-10. PubMed ID: 23880346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta.
    Mörike M; Schulz M; Brenner RE; Bushart GB; Teller WM; Vetter U
    J Cell Physiol; 1993 Dec; 157(3):439-44. PubMed ID: 8253854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.